BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 9356139)

  • 1. Determination of the relative affinities of antibody fragments expressed in Escherichia coli by enzyme-linked immunosorbent assay.
    Watkins JD; Beuerlein G; Pecht G; McFadden PR; Glaser SM; Huse WD
    Anal Biochem; 1997 Nov; 253(1):37-45. PubMed ID: 9356139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of human antibodies to cell surface antigens by capture lift screening of phage-expressed antibody libraries.
    Watkins JD; Beuerlein G; Wu H; McFadden PR; Pancook JD; Huse WD
    Anal Biochem; 1998 Feb; 256(2):169-77. PubMed ID: 9473274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
    Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
    J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo biotinylated recombinant antibodies: construction, characterization, and application of a bifunctional Fab-BCCP fusion protein produced in Escherichia coli.
    Weiss E; Chatellier J; Orfanoudakis G
    Protein Expr Purif; 1994 Oct; 5(5):509-17. PubMed ID: 7827508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and identification of phage display library for Fab fragments of colorectal cancer-related antibodies].
    Sun X; Wu BP; Xiao B; Zhang ZS; Lai ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):678-83. PubMed ID: 12376247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid kinetic-based screening of human Fab fragments.
    Steukers M; Schaus JM; van Gool R; Hoyoux A; Richalet P; Sexton DJ; Nixon AE; Vanhove M
    J Immunol Methods; 2006 Mar; 310(1-2):126-35. PubMed ID: 16481004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size of the ligand complex between the N-terminal domain of the gene III coat protein and the non-infectious phage strongly influences the usefulness of in vitro selective infective phage technology.
    Cèbe R; Geiser M
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):841-9. PubMed ID: 11104694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage.
    Tornetta M; Baker S; Whitaker B; Lu J; Chen Q; Pisors E; Shi L; Luo J; Sweet R; Tsui P
    J Immunol Methods; 2010 Aug; 360(1-2):39-46. PubMed ID: 20600082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial expression and purification of recombinant bovine Fab fragments.
    O'Brien PM; Maxwell G; Campo MS
    Protein Expr Purif; 2002 Feb; 24(1):43-50. PubMed ID: 11812221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new helper phage for improved monovalent display of Fab molecules.
    Beaber JW; Tam EM; Lao LS; Rondon IJ
    J Immunol Methods; 2012 Feb; 376(1-2):46-54. PubMed ID: 22119405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New display vector reduces biological bias for expression of antibodies in E. coli.
    Pavoni E; Monteriù G; Cianfriglia M; Minenkova O
    Gene; 2007 Apr; 391(1-2):120-9. PubMed ID: 17267141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression.
    Harvey BR; Shanafelt AB; Baburina I; Hui R; Vitone S; Iverson BL; Georgiou G
    J Immunol Methods; 2006 Jan; 308(1-2):43-52. PubMed ID: 16337958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen.
    Maeda F; Nagatsuka Y; Ihara S; Aotsuka S; Ono Y; Inoko H; Takekoshi M
    J Med Virol; 1999 Aug; 58(4):338-45. PubMed ID: 10421399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.